COVID-19 Boehringer Ingelheim NL donates 440 oxygen meters
Boehringer Ingelheim donates 440 oxygen meters to lung specialists and general practitioners during the pandemic. Click here to find out more.
Search
History video
The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Nieder-Ingelheim. Watch the video here to learn more.
Green Chemistry
Green Chemistry is critical for us as it balances the long-term sustainability of business, society, and the environment. Click here to learn more.
COVID-19 Volunteering in Mexico
Sonia Angulo, Medical Representative of Human Pharma in Mexico, has become a hero for many health workers who are facing the COVID-19 pandemic. Learn more.
COVID-19 Message from Jean Scheftsik de Szolnok
Click here to watch and hear a message from Jean Scheftsik de Szolnok, Head of the Animal Health Business Unit, Boehringer Ingelheim. Learn more here.
Podcast: Journeys through pulmonary fibrosis
As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit. Click here to listen.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
COVID-19 Supply Chain and Production
Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
In France, it’s time to be(e)
How about producing honey and contributing to environmental sustainability during your work hours? Click here to read more about this story.
The adventures of reggie the red blood cell
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
About Chronic Kidney Disease
Find out more about chronic kidney disease, it’s causes and symptoms
The NCD Initiative
Thelaziosis dog eyeworms
Most pet owners probably do not associate the scientific name “thelaziosis” to eyeworm infestations experienced by their dogs. Click here to learn more.
Quick response in fighting Foot-and-Mouth-Disease
Colleagues from the Veterinary Public Health helped to contain an outbreak of Foot-and-Mouth Disease (FMD) on the island of Rodrigues in just six days.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
COVID-19 Social distancing and pet care - A vet gives advice
We have asked Karsten Hesse, Technical Service Manager Pet at Boehringer Ingelheim from Germany, about the topic of social distancing and pet care.
Be Green Brazil – powered by nature
At Boehringer Ingelheim’s Solana farm Adrian von Treuenfels and his team cultivate the plants that supply the active ingredient for different drugs.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.
My.Making More Health Website
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting the Boehringer Ingelheim site.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.